Medication Event Monitoring System (MEMS)

DEVICE3 trials

Sponsors

Korea University Guro Hospital, Biogen, University of Colorado, Denver

Conditions

Kidney Transplant RejectionMedication AdherenceMultiple SclerosisSchizoaffective DisorderSchizophrenia

Early Phase 1

Immunosuppressant Medication Dosed Daily After Kidney Transplant

TerminatedNCT04156204

University of Colorado, DenverKidney Transplant Rejection, Medication Adherence

Start: 2019-11-20End: 2020-11-27Updated: 2020-12-02

Phase 4

Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients.

TerminatedNCT02343159

BiogenMultiple Sclerosis

Start: 2015-02-28End: 2016-04-15Updated: 2017-05-16

Unknown Phase

An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder

Korea University Guro HospitalSchizoaffective Disorder, Schizophrenia

Start: 2009-04-30End: 2010-08-31Target: 57Updated: 2009-03-13